Logo
x

Search

Subscribe Now

NeuroBo

NeuroBo’s DA-1241 Receives the US FDA’s IND Clearance to Initiate the P-IIa Clinical Trial for Nonalcoholic Steatohepatitis

NeuroBo’s DA-1241 Receives the US FDA’s IND Clearance to Initiate the P-IIa Clinical Trial for Nonalcoholic Steatohepatitis

  • May 3, 2023
NeuroBo Entered into a Conditional Exclusive License Agreement with Dong-A to Develop and Commercialize DA-1241 and DA-1726

NeuroBo Entered into a Conditional Exclusive License Agreement with Dong-A to Develop and Commercialize DA-1241 and DA-1726

  • September 16, 2022
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.